Executive Director, Clinical Development (MD), Inflammation and Immunology

Gilead Sciences•Foster City, CA

1d•$349,010 - $451,660

About The Position

At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. As an Executive Director, Clinical Development (Inflammation & Immunology), at Gilead you will lead the clinical development vision and strategy for a complex asset or portfolio within Inflammation and Immunology, including programs entering Phase 3 alongside early-phase indications. You will define how clinical evidence supports regulatory approval and long-term lifecycle value. Own development of the Target Product Profile (TPP) and Clinical Development Plan (CDP) Shape strategic decisions across multiple indications and disease areas Ensure alignment between clinical strategy, regulatory objectives, and portfolio priorities Lead Cross-Functional Execution at Scale You will operate as a Development and Evidence Team Lead (DETL), or oversee DETLs, driving execution across a highly matrixed organization. Direct cross-functional teams spanning clinical, regulatory, safety, biometrics, and medical affairs Partner closely with internal governance bodies and enterprise leadership Ensure delivery of key milestones across study design, execution, and reporting Oversee End-to-End Clinical Trial Delivery You will be accountable for the successful design, conduct, and reporting of clinical trials across the asset lifecycle. Provide leadership for protocol design, study oversight, and medical monitoring Ensure high-quality evidence generation aligned with registrational requirements Oversee data review, interpretation, and communication of results Represent the Program Externally and with Regulators You will serve as a senior scientific leader and primary clinical voice for your asset. Lead interactions with global health authorities Present data at scientific congresses and investigator meetings Contribute to publications and external scientific engagement Shape the Future of the Disease Area You will influence broader therapeutic strategy while building external partnerships and insights. Develop relationships with key opinion leaders and collaborators Contribute to disease area and portfolio strategy evolution Support business development evaluations when applicable

Requirements

MD or DO with 8+ years of clinical, scientific or drug development experience in biopharma
Board certification in hematology or rheumatology
Experience in immunology and/or benign hematology clinical trials
Demonstrated leadership of complex, cross-functional drug development programs
Experience leading Phase 2 and Phase 3 clinical development programs
Prior experience interacting with global regulatory authorities
Proven success influencing senior leadership and governance forums
Previous line management experience, including leading teams and developing talent
Strong track record of delivering complex clinical strategies and execution at scale
Exceptional communication skills with ability to translate complex science into strategic decisions
Experience managing external partnerships and collaborations

Responsibilities

Lead the clinical development vision and strategy for a complex asset or portfolio within Inflammation and Immunology, including programs entering Phase 3 alongside early-phase indications.
Define how clinical evidence supports regulatory approval and long-term lifecycle value.
Own development of the Target Product Profile (TPP) and Clinical Development Plan (CDP).
Shape strategic decisions across multiple indications and disease areas.
Ensure alignment between clinical strategy, regulatory objectives, and portfolio priorities.
Operate as a Development and Evidence Team Lead (DETL), or oversee DETLs, driving execution across a highly matrixed organization.
Direct cross-functional teams spanning clinical, regulatory, safety, biometrics, and medical affairs.
Partner closely with internal governance bodies and enterprise leadership.
Ensure delivery of key milestones across study design, execution, and reporting.
Be accountable for the successful design, conduct, and reporting of clinical trials across the asset lifecycle.
Provide leadership for protocol design, study oversight, and medical monitoring.
Ensure high-quality evidence generation aligned with registrational requirements.
Oversee data review, interpretation, and communication of results.
Serve as a senior scientific leader and primary clinical voice for your asset.
Lead interactions with global health authorities.
Present data at scientific congresses and investigator meetings.
Contribute to publications and external scientific engagement.
Influence broader therapeutic strategy while building external partnerships and insights.
Develop relationships with key opinion leaders and collaborators.
Contribute to disease area and portfolio strategy evolution.
Support business development evaluations when applicable.
Create Inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.
Develop Talent - understand the skills, experience, aspirations, and potential of their employees and coach them on current performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop, and realize their purpose.
Empower Teams - connect the team to the organization by aligning goals, purpose, and organizational objectives and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem.